Paper18393003
The role of hyperthermia in optimizing tumor response to regional therapy.
Moyer HR and 1 other. Int J Hyperthermia, 2008. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. The role of hyperthermia in optimizing tumor response to regional therapy. Papers, record 18393003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18393003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemotherapy, Cancer, Regional Perfusion | Major topic |
| Hyperthermia, Induced | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Clinical Trials as Topic | |
| Combined Modality Therapy | |
| Disease Models, Animal | |
| Humans | |
| Radiotherapy |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41090863 | Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/41090863 | PubMed |
| 40805191 | The Role of Prophylactic HIPEC in High-Risk Gastric Cancer Patients: Where Do We Stand? | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805191 | PubMed |
| 40647736 | Advances in Photothermal Electrospinning: From Fiber Fabrication to Biomedical Application. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40647736 | PubMed |
| 39199619 | Advancing Pancreatic Cancer Surgical Treatments and Proposal of New Approaches. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39199619 | PubMed |
| 37551178 | Transcriptional Regulation of the Colorectal Cancer Stem Cell Markers, Nanog and Oct4, Induced by a Thermodynamic-Based Therapy Approach. | Iran J Public Health | 2023 | https://conductscience.org/library/papers/37551178 | PubMed |
| 35408947 | Combined Therapy with Dacarbazine and Hyperthermia Induces Cytotoxicity in A375 and MNT-1 Melanoma Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35408947 | PubMed |
| 34866165 | Multifunctional Gold Nanoparticles for Improved Diagnostic and Therapeutic Applications: A Review. | Nanoscale Res Lett | 2021 | https://conductscience.org/library/papers/34866165 | PubMed |
| 31024882 | Gold Nanoparticles for Photothermal Cancer Therapy. | Front Chem | 2019 | https://conductscience.org/library/papers/31024882 | PubMed |
| 29362934 | Effect of heat stress on contractility of tissue-engineered artificial skeletal muscle. | J Artif Organs | 2018 | https://conductscience.org/library/papers/29362934 | PubMed |
| 27806300 | Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers. | Cell Rep | 2016 | https://conductscience.org/library/papers/27806300 | PubMed |
| 27404050 | Orthotopic Esophageal Cancers: Intraesophageal Hyperthermia-enhanced Direct Chemotherapy in Rats. | Radiology | 2017 | https://conductscience.org/library/papers/27404050 | PubMed |
| 26723356 | Enhancing cell kill in vitro from hyperthermia through pre-sensitizing with ultrasound-stimulated microbubbles. | J Acoust Soc Am | 2015 | https://conductscience.org/library/papers/26723356 | PubMed |
| 25976505 | The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer. | Tumour Biol | 2015 | https://conductscience.org/library/papers/25976505 | PubMed |
| 25932149 | Apoptosis-inducing effects of cetuximab combined with radiotherapy and hypothermia on human nasopharyngeal carcinoma CNE cells. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/25932149 | PubMed |
| 24649285 | Clinical experience with radio-, chemo- and hyperthermotherapy combined trimodality on locally advanced esophageal cancer. | Mol Clin Oncol | 2013 | https://conductscience.org/library/papers/24649285 | PubMed |
| 24213112 | Combined hyperthermia and radiotherapy for the treatment of cancer. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24213112 | PubMed |
| 23662149 | Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/23662149 | PubMed |
| 23637861 | Tumor angiogenesis after heated lipiodol infusion via the hepatic artery in a rabbit model of VX2 liver cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/23637861 | PubMed |
| 23092438 | Hyperthermia: from diagnostic and treatments to new discoveries. | Recent Pat Biotechnol | 2012 | https://conductscience.org/library/papers/23092438 | PubMed |
| 22951580 | Protocol for long duration whole body hyperthermia in mice. | J Vis Exp | 2012 | https://conductscience.org/library/papers/22951580 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18393003
GET https://conductscience.org/api/papers/v1/18393003/cited_by?page=2